The U.S. depyrogenated sterile empty vials market size is likely to reach USD 3.5 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.2% during the forecast period. Technological advancements in pharmaceutical packaging process, growing funding by government organizations, and flourishing biologics market in the U.S. are some of the key trends escalating market growth. Stringent regulations laid by the government for parenteral are also poised to augment the market.
Rising number of clinical labs in the country is resulting in an increased number of medical and diagnostic tests. This, in turn, is fueling the demand for depyrogenated sterile empty vials. Increasing number of compounding laboratories and research institutes in the U.S. is boosting the demand for these vials in the market. Moreover, continual growth in the pharmaceutical and biotechnology industry is further projected to drive the market.
Increasing number of collaborations in order to achieve innovative packaging technology is also providing an upthrust to the market. Rising incidence of infectious & non-infectious diseases and growing number of clinical studies are translating into a greater demand for these vials. Besides this, the government is backing the promotion of pharmaceutical, medical, and biotechnological researches, which is anticipated to work in favor of the market.
Request a sample Copy of the U.S. Depyrogenated Sterile Empty Vials Market Research Report @ https://www.grandviewresearch.com/industry-analysis/us-depyrogenated-sterile-empty-vials-market/request/rs1
Key Takeways Of The Report :
- More than 20 ml depyrogenated sterile empty vials emerged as the largest segment in terms of revenue in 2017 owing to rising incidence of infectious & non-infectious diseases and increasing investments in the biopharmaceutical sector
- Others, which include pharmaceutical manufacturers and academic & research institutes, formed the most prominent end-use segment in 2017. The growth of the segment can be attributed to expanding base of medical & biotech research institutes and upswing in pharmaceutical manufacturing
- Thermo Fisher Scientific, Inc.; Gerresheimer AG; SCHOTT AG; and DWK Life Sciences are the major players operating in the market. This market is considerably fragmented and market entry barrier is high.
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/5478/ibb
Grand View Research has segmented the U.S. depyrogenated sterile empty vials market on the basis of product and end-use:
Depyrogenated Sterile Empty Vials Product Outlook (Revenue, USD Million, 2014 – 2025)
- 2 ml
- 5 ml
- 10 ml
- 20 ml
- More than 20 ml
Depyrogenated Sterile Empty Vials End-use Outlook (Revenue, USD Million, 2014 – 2025)
- Clinical Labs
- Compounding Labs
Browse Related Report:
Mobile Stroke Unit (MSTU) Market : https://www.grandviewresearch.com/industry-analysis/mobile-stroke-unit-market
Medical Laser Systems Market : https://www.grandviewresearch.com/industry-analysis/medical-laser-system-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States